Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. (Q53599778)

16 May 2018

title

Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. (English)

1 reference

16 May 2018

1 reference

1 reference

Sung YM

1

1 reference

16 May 2018

He G

series ordinal

2

1 reference

16 May 2018

Hwang DH

series ordinal

3

1 reference

16 May 2018

Fischer SM

series ordinal

4

1 reference

16 May 2018

language of work or name

English

0 references

publication date

10 April 2006

1 reference

16 May 2018

published in

Oncogene

1 reference

16 May 2018

volume

25

1 reference

16 May 2018

page(s)

5507-5516

1 reference

16 May 2018

issue

40

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209538

exact match

0 references

cites work

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Regulation of vascular endothelial cell growth factor expression in mouse mammary tumor cells by the EP2 subtype of the prostaglandin E2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Relationship between the proliferation of keratinocytes cultured in vitro and prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Histological and genetic changes in malignant transformation of gallbladder adenoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Promising molecular targets for cancer prevention: AP-1, NF-kappa B and Pdcd4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209538

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209538

1 reference

16 May 2018

PubMed ID

16607275

1 reference

16 May 2018